Abstract

The objective of the study was to perform a bibliometric analysis of the Pfizer-BioNTech vaccine. For this purpose Scopus database was used. As of 13th May 2021, one hundred and seventy-three (n=173) research documents are published about it. We used Vosviewer and Biblioshiny (Bibliometrix) in the present report. In all publications, 1160 authors have significantly contributed. The documents per author was 0.119, while authors per document was 8.41. Collaborative Index (CI) was found to be 9.47. By biblioshiny we also applied Lotka’s law to depict the author’s frequency. 1097 authors were involved in only one (n=1) publication. Based on the Scopus record, the highest documents are published by Dormitzer, P.R. (n=6). In universities and countries categories, Tel Aviv University (n=7) and USA (48) are the most productive. By Vosviewer the collaboration pattern among authors, institutes, and countries is graphically presented. For example, 28 authors, 17 departments and 7 countries directly contributed to one publication. The research documents (133) are published in 102 sources or journals. The highest documents are published in Vaccines (n=8), while the highest citations were recorded for the New England Journal of Medicine (n=838). We also applied co-words analysis to understand the main focus of these publications.

Highlights

  • Coronavirus disease 2019 (COVID-19), is a highly transmissible global pandemic

  • Total one hundred and seventy three (n=173) research documents are published about Pfizer-BioNTech vaccine

  • For detail analysis we focused on articles and reviews (n=133) with 1359 citations

Read more

Summary

Introduction

Coronavirus disease 2019 (COVID-19), is a highly transmissible global pandemic. It was 1st detected and identified in Wuhan, China, in December 2019. It causes an infection in nose, sinuses, upper throat or lower respiratory tract (windpipe and lungs). Some of the major sympotoms are fever, coughing, shortness of breath, trouble breathing, fatigue, chills, sometimes with shaking, body aches, headache, sore throat, congestion/runny nose, loss of smell or taste, nausea, and diarrhea. The virus can lead to pneumonia, respiratory failure, heart problems, liver problems, septic shock, and may lead to death. According to WHO, globally, there have been 160,074,267 confirmed cases of COVID-19, including 3,325,260 deaths (till 14th May, 2021)

Objectives
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call